These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Product quality control testing for the oral polio vaccine. Brock B; Kelleher L; Zlotnick B Dev Biol Stand; 1998; 94():217-9. PubMed ID: 9776242 [TBL] [Abstract][Full Text] [Related]
5. Vaccines produced in diploid cell lines. Ikić D Natl Cancer Inst Monogr; 1968 Dec; 29():485-93. PubMed ID: 4976866 [No Abstract] [Full Text] [Related]
6. A paramyxovirus causing fatal gastroenterocolitis in marmoset monkeys. Fraser CE; Chalifoux L; Sehgal P; Hunt RD; King NW Primates Med; 1978; 10():261-70. PubMed ID: 417328 [TBL] [Abstract][Full Text] [Related]
7. Prospects for a rubella virus vaccine. Parkman PD; Meyer HM Prog Med Virol; 1969; 11():80-106. PubMed ID: 4984711 [No Abstract] [Full Text] [Related]
8. Clinical experience with vaccines produced in the human diploid cell line WI-38. Andzaparidze OG Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367 [No Abstract] [Full Text] [Related]
9. Molecular consistency monitoring of oral poliovirus vaccine and other live viral vaccines. Chumakov KM Dev Biol Stand; 1999; 100():67-74. PubMed ID: 10616177 [No Abstract] [Full Text] [Related]
10. R75761, a lead compound for the development of antiviral drugs in late stage poliomyelitis eradication strategies and beyond. Thys B; De Palma AM; Neyts J; Andries K; Vrijsen R; Rombaut B Antiviral Res; 2008 Jun; 78(3):278-81. PubMed ID: 18294707 [TBL] [Abstract][Full Text] [Related]
11. The potential use of viral genomic markers in estimating the neurovirulence of oral poliomyelitis vaccine (OPV): regulatory aspects. Fenyves A Dev Biol Stand; 1993; 78():157-9. PubMed ID: 8388826 [No Abstract] [Full Text] [Related]
12. Development of a 1-step cell-based assay for cost-effective screening of antiviral drugs for vaccinia virus. Jesus DM; Santos ES; Schnellrath LC; Damaso CR Diagn Microbiol Infect Dis; 2009 Jul; 64(3):350-3. PubMed ID: 19395220 [TBL] [Abstract][Full Text] [Related]
13. Studies on the mutagenic action of proflavine on type 3 poliovirus. Pervikov YV; Vorohsilova MK; Chumakov MP; Savinov AP; Yurovetskaya AL Acta Virol; 1973 Jul; 17(4):365. PubMed ID: 4148222 [No Abstract] [Full Text] [Related]
14. Studies of some substances with antiviral activity. 3. The inhibition of poliovirus type 1 and 2 induced cytopathogenic changes in cell cultures of human embryonic kidneys by derivatives of thiazolidine acetic acid. Schauer P; Likar M; Tisler M; Krbavcic A Pathol Microbiol (Basel); 1966; 29(4):506-12. PubMed ID: 4288654 [No Abstract] [Full Text] [Related]
15. Tunicamycin, a new antibiotic. II. Some biological properties of the antiviral activity of tunicamycin. Takatsuki A; Tamura G J Antibiot (Tokyo); 1971 Apr; 24(4):224-31. PubMed ID: 5103138 [No Abstract] [Full Text] [Related]
16. [Prerequisites for neurovirological and neurotoxicological tests in animal experiment]. Glees P Dtsch Med Wochenschr; 1968 Dec; 93(49):2383-6 passim. PubMed ID: 4301399 [No Abstract] [Full Text] [Related]
17. Mixed culture cytopathogenicity induced by virus preparations derived from cultures infected by simian sarcoma virus. Rangan SR; Wong MC; Ueberhorst PJ; Ablashi DV J Natl Cancer Inst; 1972 Aug; 49(2):571-7. PubMed ID: 4627750 [No Abstract] [Full Text] [Related]
19. Rabies vaccine prepared from the virus grown in Japanese quail embryo cell cultures. Bektemirova MS; Pille ER; Matevosyan KS; Nagieva FG Acta Virol; 1983 Jan; 27(1):59-64. PubMed ID: 6133431 [TBL] [Abstract][Full Text] [Related]
20. Production and control of live oral poliovirus vaccine in WI-38 human diploid cells. Stones PB Dev Biol Stand; 1976 Dec 13-15; 37():251-3. PubMed ID: 1036401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]